Mesa Laboratories, Inc. (MLAB) Cash Flow Statement
Mesa Laboratories, Inc. (MLAB) generated $55.7M of operating cash flow over the twelve months to 2026-06-30, spent $2.8M on capital expenditure and had free cash flow of $52.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MLABMesa Laboratories, Inc.Follow MLAB — free
—
Price chart with a free account
- Market cap
- 720.0M
- P/E TTM
- —
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Mar 17 | FY2018 Mar 18 | FY2019 Mar 19 | FY2020 Mar 20 | FY2021 Mar 21 | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 12.5 | 11.4 | 12.4 | 10.8 | 16.9 | 7.8 | 25.7 | 30.6 | 27.0 | 37.1 | 39.2 | 28.0 | 44.1 | 46.8 | 42.8 | 55.7 | |
| Capital expenditure | — | — | — | — | — | — | — | — | 1.5 | 2.0 | 4.4 | 4.5 | 2.6 | 4.2 | 3.3 | -2.8 | |
| Free cash flow | — | — | — | — | — | — | — | — | 25.5 | 35.1 | 34.8 | 23.4 | 41.6 | 42.6 | 39.6 | 52.9 | |
| Dividends paid | 1.6 | 1.8 | 2.0 | 2.2 | 2.3 | 2.4 | 2.4 | 2.5 | 2.7 | 3.2 | 3.3 | 3.4 | 3.4 | 3.5 | 3.5 | — | |
| Share repurchases | 0.6 | 0.1 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation | 0.5 | 1.1 | 0.8 | 1.0 | 1.3 | 1.4 | 1.7 | 4.2 | 5.5 | 9.3 | 11.4 | 12.5 | 11.9 | 13.1 | 17.9 | — |
USD millions · SEC XBRL
Mesa Laboratories, Inc. — questions
- What is Mesa Laboratories, Inc.'s operating cash flow?
- $55.7M over the twelve months to 2026-06-30.
- How much does Mesa Laboratories, Inc. spend on capital expenditure?
- $2.8M over the twelve months to 2026-06-30.
- What is Mesa Laboratories, Inc.'s free cash flow?
- $52.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Mesa Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.